SensoDetect Investor Relations Material
Latest events
Q1 2025
30 Apr, 2025
Q4 2024
21 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SensoDetect
Access all reports
SensoDetect AB is a Sweden-based medical technology company specializing in objective diagnostic tools for mental health. The company develops and markets the SensoDetect BERA system, which uses auditory brainstem response analysis to support the diagnosis of neuropsychiatric disorders such as ADHD, autism, and schizophrenia. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SDET
Country
🇸🇪 Sweden